Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) Invested Capital (2016 - 2025)

Historic Invested Capital for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $442.5 million.

  • Orthofix Medical's Invested Capital fell 1685.31% to $442.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $442.5 million, marking a year-over-year decrease of 1685.31%. This contributed to the annual value of $510.2 million for FY2024, which is 1495.98% down from last year.
  • Orthofix Medical's Invested Capital amounted to $442.5 million in Q3 2025, which was down 1685.31% from $458.3 million recorded in Q2 2025.
  • Orthofix Medical's 5-year Invested Capital high stood at $664.2 million for Q1 2023, and its period low was $333.5 million during Q3 2022.
  • Its 5-year average for Invested Capital is $464.8 million, with a median of $458.3 million in 2025.
  • Its Invested Capital has fluctuated over the past 5 years, first surged by 9791.67% in 2023, then plummeted by 2007.99% in 2025.
  • Orthofix Medical's Invested Capital (Quarter) stood at $354.1 million in 2021, then dropped by 4.6% to $337.9 million in 2022, then surged by 77.58% to $600.0 million in 2023, then dropped by 14.96% to $510.2 million in 2024, then dropped by 13.28% to $442.5 million in 2025.
  • Its Invested Capital stands at $442.5 million for Q3 2025, versus $458.3 million for Q2 2025 and $458.3 million for Q1 2025.